Skip to content
Join
Microbiomehub
Sign In
Search
  • Topics
    Scientific News
    Allergology
    Cardiology
    Dentistry
    Dermatology
    Endocrinology
    Gastroenterology
    Geriatrics
    Gynecology
    Infectiology
    Immunology
    Nephrology
    Neuroscience
    Nutrition
    Oncology
    Ophthalmology
    See all scientific news
    Industry news
    The story of three new probiotics: from infancy to discovery
    Faecalibacterium prausnitzii: a microbiome-based candidate for IBD, C. diff and cancer
    Gut bacteria and metabolites may be drivers of chronic pain in sickle cell disease
    Maternal microbes may trigger preterm birth by altering pregnancy hormones
    See all industry news
  • Archives
    Video interviews
    Faecalibacterium prausnitzii: a microbiome-based candidate for IBD, C. diff and cancer
    Standardizing evidence on probiotics in acute gastroenteritis: why guidelines diverge and clinicians are confused
    See all video inteviews
    Webinars
    Supporting women’s health through menopause: probiotic insights from IFF Health
    Consumer behavior in probiotic consumption
    See all webinars
    Podcasts
    Gut-Brain Theory – Episode 3: Insomnia, anxiety and the microbiome
    Gut-Brain Theory – Episode 2: The link between gut and depression
    See all podcasts
    Companies Resources
    SynbiOFF® Line – Product List
    SynbÆctive® Formulations – Table of Life
    See all companies
  • MicrobiomeHUB

    Your go-to destination to spotlight your products and services while connecting with high-value leads in the microbiome space

    Partners
    Learn More
  • Probiotic database
    Probiotic strains
    Cardiometabolic
    Gastrointestinal
    Gut-brain Axis
    Healthy Ageing
    Immune System
    Oral Care
    Skin Health
    Sport
    Urogenital
    Weight Management
    Women's Health
    See all strains
    Latest probiotic blends
    Synbiotics by Probi® and Clasado
    Probi® Sensia
    SynbÆctive® KeepCalm
    SynbÆctive® MetSyn
    SynbÆctive® Wellderly
    SynbÆctive® ProBeautyShield
    SynbÆctive® Femme
    SynbÆctive® SmilinGut
    SynbÆctive® DefensePlus
    See all blends
  • Events
Newsletter

Home > Industry > Akkermansia municiphila on the market before the end of 2022

Akkermansia municiphila on the market before the end of 2022

author
Staff editor
author
12.04.2022
Patrice Cani (Université catholique de Louvain) discusses the future of Akkermansia municiphila.

Latest related content

Pediatrics, Industry

The story of three new probiotics: from infancy to discovery

Video, Gastroenterology

Faecalibacterium prausnitzii: a microbiome-based candidate for IBD, C. diff and cancer

Scientific research

Gut bacteria and metabolites may be drivers of chronic pain in sickle cell disease

Gynecology

Maternal microbes may trigger preterm birth by altering pregnancy hormones

Uncategorized, Gastroenterology

Standardizing evidence on probiotics in acute gastroenteritis: why guidelines diverge and clinicians are confused

Neuroscience

Gut-brain connection may be a predictor of Alzheimer’s and Parkinson’s risk

Latest News

Pediatrics, Industry

The story of three new probiotics: from infancy to discovery

Video, Gastroenterology

Faecalibacterium prausnitzii: a microbiome-based candidate for IBD, C. diff and cancer

Scientific research

Gut bacteria and metabolites may be drivers of chronic pain in sickle cell disease

Gynecology

Maternal microbes may trigger preterm birth by altering pregnancy hormones

Uncategorized, Gastroenterology

Standardizing evidence on probiotics in acute gastroenteritis: why guidelines diverge and clinicians are confused

Neuroscience

Gut-brain connection may be a predictor of Alzheimer’s and Parkinson’s risk

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Subscribe
Microbiome Post
MicrobiomePost
  • Advertise with us
  • About us
  • Contact us
Microbiomehub
MicrobiomeHUB
  • What is MicrobiomeHUB
  • Help Center
Follow us
Linkedin X-twitter Facebook-f
© 2018-2025 Clorofilla Scientific Publishing

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

© ALL RIGHTS RESERVED

Read MicrobiomePost’s Privacy Policy

This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.

Scroll to Top
Sign In
Scientific News
Industry news
Video interviews
Webinars
Podcasts
Join
Companies
Probiotic strains
Probiotic blends
Event calendar
Sign Up for Free Microbiome Newsletter
Keep up to date with the latest business & market news on microbiome space with our free newsletter.

By submitting this form, you acknowledge that you have read and understand our Privacy Policy

X